Fibroblast silver loading for the diagnosis of Menkes disease

J Med Genet. 1998 Oct;35(10):849-51. doi: 10.1136/jmg.35.10.849.

Abstract

Menkes disease is a genetic disorder of copper metabolism. Copper uptake and retention assays on fibroblast or amniotic fluid cell cultures have been used for pre- and postnatal diagnosis. These copper loading tests are complicated by the use of 64Cu, which is not commonly available and has a very short (12.8 hours) physical half life. Besides copper, silver is also a substrate for the bacterial homologue of the Menkes transport protein. We report here that loading tests using radioactive silver (110mAg), instead of copper, can be used for the diagnosis of Menkes disease. 110mAg is commercially available and has a convenient physical half life of 250 days, which makes it suitable for use in diagnostic laboratories. Our studies support the hypothesis that reduction of divalent to monovalent copper is an essential step preceding transport.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphatases / genetics
  • Adenosine Triphosphatases / metabolism
  • Amniotic Fluid / cytology
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cation Transport Proteins*
  • Cells, Cultured
  • Copper / metabolism
  • Copper-Transporting ATPases
  • Female
  • Fibroblasts / metabolism
  • Humans
  • Menkes Kinky Hair Syndrome / diagnosis*
  • Menkes Kinky Hair Syndrome / genetics
  • Pregnancy
  • Prenatal Diagnosis
  • Radioisotopes
  • Recombinant Fusion Proteins*
  • Silver* / metabolism
  • Time Factors

Substances

  • Carrier Proteins
  • Cation Transport Proteins
  • Radioisotopes
  • Recombinant Fusion Proteins
  • Silver
  • Copper
  • Adenosine Triphosphatases
  • ATP7A protein, human
  • Copper-Transporting ATPases